risankizumab
abbvie
['fortify', 'crohn', 'risan', 'ibd']
 il-23 inhibitors are coming- you better learn how to pronounce them risankizumab: 1. effective in bioexperienced cd 2. high rates of mucosal healing 3. rescue is possible 4. 20% benefit in pts who failed il12/23 5. great safety #aibd2022 
IBD doctor @OHSU | Life and Health Coach | Tweets are my own and are not medical advice